BiotechTubeBiotechTube
Home/Disc Medicine/Jonathan Yu
JY

Jonathan Yu

Chief Operating Officer

Disc Medicine

Therapeutic Areas

HematologyRare DiseasesOncologyNephrologyGastroenterology

Disc Medicine Pipeline

DrugIndicationPhase
BitopertinErythropoietic Protoporphyria (EPP) & X-Linked Protoporphyria (XLP)Phase 3
DISC-0974Anemia of Myelofibrosis (MF)Phase 2
DISC-0998Anemia Associated with Inflammatory DiseasesPreclinical
DISC-3405Polycythemia VeraPhase 2

Leadership Team at Disc Medicine

JQ
John Quisel
Chief Executive Officer
JF
Jean Franchi
Chief Financial Officer
WS
Will Savage
Chief Medical Officer
PS
Pamela Stephenson
Chief Commercial Officer
SC
Steve Caffé
Chief Regulatory Officer
RR
Rahul Rajan Kaushik
Chief Technical Officer
RK
Rahul Khara
Chief Legal Officer
LA
Lisa Amaya Price
Chief Human Resources Officer
SV
Srikanth Venkatraman
SVP, Head of Chemistry
HY
Hua Yang
SVP, Head of Early Development and Clinical Pharmacology
View full Disc Medicine profile